日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment

乳腺癌中线粒体发病机制的综述及靶向线粒体治疗乳腺癌的进展

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06077-2
Huang, Aoling; Xue, Haochen; Xie, Ting; Xiang, Lingyan; Chen, Zhengzhuo; Ma, Aolong; Yan, Honglin; Yuan, Jingping
肿瘤
线粒体
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Integrating Machine Learning and Bulk and Single-Cell RNA Sequencing to Decipher Diverse Cell Death Patterns for Predicting the Prognosis of Neoadjuvant Chemotherapy in Breast Cancer.

整合机器学习、批量和单细胞 RNA 测序技术，以解读多样化的细胞死亡模式，从而预测乳腺癌新辅助化疗的预后

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26083682
Xiang Lingyan, Yang Jiajun, Rao Jie, Ma Aolong, Liu Chen, Zhang Yuqi, Huang Aoling, Xie Ting, Xue Haochen, Chen Zhengzhuo, Yuan Jingping, Yan Honglin
细胞生物学
乳腺癌
单细胞
发表日期：2025
文献求助 收藏

Advancements in technology for characterizing the tumor immune microenvironment

肿瘤免疫微环境表征技术进展

期刊:International Journal of Biological Sciences
影响因子:10
doi:10.7150/ijbs.92525
Yan, Honglin; Ju, Xianli; Huang, Aoling; Yuan, Jingping
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

Artificial intelligence: illuminating the depths of the tumor microenvironment

人工智能：揭示肿瘤微环境的奥秘

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-024-05609-6
Xie, Ting; Huang, Aoling; Yan, Honglin; Ju, Xianli; Xiang, Lingyan; Yuan, Jingping
肿瘤
肿瘤微环境
肿瘤免疫
发表日期：2024
文献求助 收藏

Performance of a HER2 testing algorithm tailored for urothelial bladder cancer: A Bi-centre study

针对尿路上皮膀胱癌定制的HER2检测算法的性能：一项双中心研究

期刊:Computational and Structural Biotechnology Journal
影响因子:4.1
doi:10.1016/j.csbj.2024.10.007
Huang, Aoling; Zhao, Yizhi; Guan, Feng; Zhang, Hongfeng; Luo, Bin; Xie, Ting; Chen, Shuaijun; Chen, Xinyue; Ai, Shuying; Ju, Xianli; Yan, Honglin; Yang, Lin; Yuan, Jingping
HER2
肿瘤
肿瘤免疫
膀胱癌
发表日期：2024
文献求助 收藏

Comparison of clinicopathological characteristics, efficacy of neoadjuvant therapy, and prognosis in HER2-low and HER2-ultralow breast cancer

比较 HER2 低表达和 HER2 超低表达乳腺癌的临床病理特征、新辅助治疗疗效和预后

期刊:Diagnostic Pathology
影响因子:2.3
doi:10.1186/s13000-024-01557-3
Guan, Feng; Ju, Xianli; Chen, Lixia; Ren, Jiacai; Ke, Xiaokang; Luo, Bin; Huang, Aoling; Yuan, Jingping
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏